Here are 14 key notes on orthopedic and spine device companies from the past week.
NuVasive acquired Vertera Spine, a medical device company focused on interbody implants using patented porous polyetheretheketone technology.
The Dow Jones Sustainability North American Index's 2017 list of sustainable companies included Medtronic for the 10th year in a row.
Medtronic launched new long term clinical studies to collect prospective data on posterolateral fusion and transforaminal lumbar interbody fusion procedures using Infuse Bone Graft.
Life Spine's division, Centric Medical, reported record revenue growth of its foot and ankle as well as biologics product lines.
Mazor Robotics' shares reached a new 52-week high of $49.64 on Sept. 1.
NuVasive received FDA clearance for its redesigned Magec system including its Reline Small Stature system.
The FDA granted Spinal Resources 510(k) clearance for the Swedge Pedicle Screw System.
For the first half of 2017, Mainstay Medical reported $250,000 in revenues and $12.3 million in operating expenses.
Jason Hannon will take the helm of Mainstay Medical Oct. 9.
ApiFix entered into an exclusive distribution agreement with Joint Solutions Alliance Corp. in Canada.
Smith & Nephew signed a three year partnership with Imperial College London to develop enhanced surgical techniques relating to ligament function, biomechanics and knee soft tissue injuries.
Bioventus received FDA clearance for Durolane, a single injection hyaluronic acid device used for joint lubrication in the treatment of knee osteoarthritis pain.
Amedica adjourned a special stockholder meeting, scheduled for Sept. 7.
The Medacta Orthopaedic Research and Education Institute is hosting its 250th MORE AMIS Learning Center for surgeons to learn Medacta's anterior minimally invasive surgery techniques.